Viewing Study NCT00802568


Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2026-05-09 @ 8:34 AM
Study NCT ID: NCT00802568
Status: COMPLETED
Last Update Posted: 2011-05-16
First Post: 2008-12-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment
Sponsor: Institut Paoli-Calmettes
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma and Plasma Cell Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage I multiple myeloma View
None stage II multiple myeloma View
None stage III multiple myeloma View
None refractory multiple myeloma View
None osteolytic lesions of multiple myeloma View